Skip to the page

Data / Drug companies / Allergan, Inc.

Allergan, Inc.: 70 products in the FDA NDC directory, labeler code 0023

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Allergan, Inc. (labeler code 0023) lists 70 products in the FDA National Drug Code Directory, covering 28 finished drugs by generic name. By type: 36 over the counter drugs, 26 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 9, 2026.

The request: Watch Allergan, Inc. (FDA labeler code 0023): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0023
Products in commercial distribution
70
Packages
145
Finished drugs by generic name
28
Prescription products
26
Over the counter products
36
Flagged as original packager
53 of 53 products that carry the flag
Started marketing in the last 12 months
3
Earliest marketing start
April 29, 1974
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs3347.1%
New drug applications (NDA)2434.3%
Drugs for further processing68.6%
Biologics (BLA)45.7%
Bulk ingredients22.9%
Unapproved homeopathic products11.4%

Products by type

TypeProductsShare
Over the counter drugs3651.4%
Prescription drugs2637.1%
Drugs for further processing68.6%
Bulk ingredients22.9%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Carboxymethylcellulose sodium and glycerin61
Carboxymethylcellulose sodium530
Carboxymethylcellulose sodium, glycerin and polysorbate 8041
Onabotulinumtoxina42
Carboxymethylcellulose sodium, glycerin36
Bimatoprost315
Mineral oil, petrolatum31
Ketorolac tromethamine369
Carboxymethylcellulose sodium, glycerin, polysorbate 8031
Cyclosporine224
Progesterone239
Ubrogepant22
Oxybutynin26
Salicylic acid2330
Brimonidine tartrate215
Alcaftadine24
Titanium dioxide and zinc oxide246
Levonorgestrel131
Octinoxate, octisalate, titanium dioxide and zinc oxide11
Zinc oxide and octinoxate12
Iron dextran13
Arnica montana and ledum palustre twig11
Brimonidine tartrate, timolol maleate11
Carboxymethylcellulose sodium, glycerin, and polysorbate 8011
Gatifloxacin13
Polyvinyl alcohol, povidone118
Dexamethasone145
Octinoxate, octisalate and zinc oxide11

Dosage forms

Dosage formProductsShare
Solution/ drops3144.3%
Lotion68.6%
Liquid57.1%
Tablet45.7%
Gel45.7%
Injection, powder, lyophilized, for solution45.7%
Ointment34.3%
Patch34.3%
Emulsion22.9%
Kit22.9%
Powder22.9%
Implant22.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Carboxymethylcellulose sodium0023-8027LiquidDrugs for further processingJuly 9, 2026
Carboxymethylcellulose sodium0023-8026LiquidDrugs for further processingJuly 2, 2026
Refresh Optive Mega-3 PF0023-3988Solution/ dropsOver the counter monograph drugsMarch 1, 2026
Botulinum toxin type a0023-5028PowderDrugs for further processingNovember 4, 2024
Botulinum toxin type a0023-5027PowderDrugs for further processingOctober 15, 2024
REFRESH Optive Mega-30023-4230Solution/ dropsOver the counter monograph drugsJuly 1, 2024
SkinMedica Acne Clarifying Treatment0023-1230LotionOver the counter monograph drugsApril 9, 2024
Refresh Relieva PF Xtra0023-3782Solution/ dropsOver the counter monograph drugsMarch 1, 2024
Refresh tears pf0023-3110Solution/ dropsOver the counter monograph drugsMarch 1, 2024
Botulinum toxin type a0023-1111LiquidBulk ingredientsFebruary 29, 2024
Lastacaft0023-4291Solution/ dropsNew drug applications (NDA)December 1, 2021
REFRESH Optive Mega-30023-7151Solution/ dropsOver the counter monograph drugsJune 15, 2021
Refresh RELIEVA PF0023-9537Solution/ dropsOver the counter monograph drugsSeptember 25, 2020
Refresh RELIEVA PF0023-4515Solution/ dropsOver the counter monograph drugsSeptember 25, 2020
OcuMend Healing Gels0023-6934PatchUnapproved homeopathic productsSeptember 1, 2020
Refresh Digital PF0023-6954Solution/ dropsOver the counter monograph drugsAugust 1, 2020
Refresh Digital0023-6952Solution/ dropsOver the counter monograph drugsAugust 1, 2020
Durysta0023-9652ImplantNew drug applications (NDA)March 4, 2020
Ubrogepant0023-6502TabletDrugs for further processingDecember 23, 2019
Ubrelvy0023-6501TabletNew drug applications (NDA)December 23, 2019
Ubrogepant0023-6499TabletDrugs for further processingDecember 23, 2019
Ubrelvy0023-6498TabletNew drug applications (NDA)December 23, 2019
Refresh Relieva Preservative Free0023-6634Solution/ dropsOver the counter monograph drugsJuly 26, 2019
Refresh Relieva0023-6630Solution/ dropsOver the counter monograph drugsJuly 22, 2019
REFRESH Optive Mega-30023-5773Solution/ dropsOver the counter monograph drugsMay 30, 2017

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.